All Stories

  1. The Aurora kinase B relocation blocker LXY18 triggers mitotic catastrophe selectively in malignant cells
  2. In-vitro metabolism of LXY18, an orally available, potent blocker of AURKB relocation in mitosis
  3. Orally Bioavailable 4-Phenoxy-quinoline Compound as a Potent Aurora Kinase B Relocation Blocker for Cancer Treatment
  4. Characterization of mitotic phenotypes associated with a MYC synthetic lethal compound
  5. Integrating a phenotypic screening with a structural simplification strategy to identify 4-phenoxy-quinoline derivatives to potently disrupt the mitotic localization of Aurora kinase B
  6. An orally bioavailable 4-phenoxy-quinoline compound as a potent AURKB relocation blocker for cancer treatment
  7. 2-Phenoxy-3, 4′-bipyridine derivatives inhibit AURKB-dependent mitotic processes by disrupting its localization
  8. The phytochemical, corynoline, diminishes Aurora kinase B activity to induce mitotic defect and polyploidy
  9. The Phytochemical Scoulerine Inhibits Aurora Kinase Activity to Induce Mitotic and Cytokinetic Defects
  10. A high-content screen identifies the vulnerability of MYC-overexpressing cells to dimethylfasudil
  11. Aberrant Activation of Notch1 Signaling in Glomerular Endothelium Induces Albuminuria
  12. A high-content screen for anti-mitosis and polyploidy-induction identifies an unknown activity of two benzophenanthridine alkaloids from Corydalis longicalcarata
  13. The anti-apoptotic proteins Bcl-2 and Bcl-xL suppress Beclin 1/Atg6-mediated lethal autophagy in polyploid cells
  14. Purification, identification, and characterization of two benzophenanthridine alkaloids fromCorydalis longicalcaratarhizomes with anti-mitotic and polyploidy-inducing activities
  15. A high-content screen identifies the vulnerability of MYC-overexpressing cells to dimethylfasudil
  16. The anti-apoptotic proteins Bcl-2 and Bcl-xL suppress Beclin1/Atg6-mediated lethal autophagy in polyploid cells
  17. Metabolic reprogramming and Notch activity distinguish between non-small cell lung cancer subtypes
  18. Notch1 activates angiogenic regulator Netrin4 in endothelial cells
  19. Dihydroartemisinin ameliorates sepsis-induced hyperpermeability of glomerular endothelium via up-regulation of occludin expression
  20. GATA3-induced vWF upregulation in the lung adenocarcinoma vasculature
  21. Dihydroartemisinin up-regulates VE-cadherin expression in human renal glomerular endothelial cells
  22. Glomerular endothelial cell IQGAP2 and filtration barrier function
  23. Plasma von Willebrand factor level is transiently elevated in a rat model of acute myocardial infarction
  24. Trichostatin A suppresses lung adenocarcinoma development in Grg1 overexpressing transgenic mice
  25. CD109 is specifically expressed in endothelial cells of cutaneous cavernous haemangioma
  26. Dihydroartemisinin targets VEGFR2 via the NF-κB pathway in endothelial cells to inhibit angiogenesis
  27. Dihydroartemisinin inhibits vascular endothelial growth factor-induced endothelial cell migration by a p38 mitogen-activated protein kinase-independent pathway
  28. Postnatal Notch1 activation induces T-cell malignancy in conditional and inducible mouse models
  29. Cadmium induces vascular permeability via activation of the p38 MAPK pathway
  30. Sox9 mediates Notch1-induced mesenchymal features in lung adenocarcinoma
  31. The Metabolic Profile of Tumors Depends on Both the Responsible Genetic Lesion and Tissue Type
  32. Activated Notch1 Induces Lung Adenomas in Mice and Cooperates with Myc in the Generation of Lung Adenocarcinoma
  33. Interaction between MYC and MCL1 in the Genesis and Outcome of Non–Small-Cell Lung Cancer
  34. Id1 cooperates with oncogenic Ras to induce metastatic mammary carcinoma by subversion of the cellular senescence response
  35. Grg1 Acts as a Lung-Specific Oncogene in a Transgenic Mouse Model
  36. TALE Homeoproteins as HOX11-Interacting Partners in T-cell Leukemia
  37. Cutaneously applied acyclovir acts systemically in the treatment of herpetic infection in the hairless mouse